USANA Health Sciences (NYSE:USNA – Get Free Report) is set to announce its earnings results after the market closes on Tuesday, April 30th. Analysts expect the company to announce earnings of $0.69 per share for the quarter. USANA Health Sciences has set its FY 2024 guidance at 2.400-3.000 EPS.Investors interested in listening to the company’s conference call can do so using this link.
USANA Health Sciences (NYSE:USNA – Get Free Report) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $0.87 earnings per share for the quarter, beating analysts’ consensus estimates of $0.52 by $0.35. The company had revenue of $221.08 million for the quarter, compared to analysts’ expectations of $206.70 million. USANA Health Sciences had a return on equity of 13.49% and a net margin of 6.93%. On average, analysts expect USANA Health Sciences to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.
USANA Health Sciences Trading Up 0.8 %
Shares of NYSE USNA opened at $43.47 on Friday. The stock has a market cap of $836.36 million, a price-to-earnings ratio of 13.17, a P/E/G ratio of 1.32 and a beta of 0.91. USANA Health Sciences has a 1-year low of $42.59 and a 1-year high of $69.60. The stock’s 50-day moving average is $47.06 and its 200 day moving average is $48.77.
Wall Street Analysts Forecast Growth
Check Out Our Latest Analysis on USNA
Insider Activity at USANA Health Sciences
In other USANA Health Sciences news, Chairman Kevin Guest sold 11,011 shares of USANA Health Sciences stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $49.00, for a total value of $539,539.00. Following the transaction, the chairman now directly owns 10,491 shares of the company’s stock, valued at approximately $514,059. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other USANA Health Sciences news, Chairman Kevin Guest sold 11,011 shares of USANA Health Sciences stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $49.00, for a total value of $539,539.00. Following the transaction, the chairman now directly owns 10,491 shares of the company’s stock, valued at approximately $514,059. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Walter Noot sold 5,240 shares of USANA Health Sciences stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $49.05, for a total value of $257,022.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 24,807 shares of company stock valued at $1,200,791. Corporate insiders own 0.33% of the company’s stock.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Featured Stories
- Five stocks we like better than USANA Health Sciences
- How to Invest in the FAANG Stocks
- MarketBeat Week in Review – 4/22 – 4/26
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Stocks Leading the U.S. Agriculture Comeback
- Profitably Trade Stocks at 52-Week Highs
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.